Policies and Procedures — Page 4 
4. If a grant is interrupted for valid reasons, written permission must be obtained 
from the Medical and Scientific Advisory Committee, so that it may be continued at a 
later date. In the event that a grant is not completed due to incapacitating illness 
or death of the Grantee, the unexpended balance of the funds must be returned to the 
Society. 
5. The Grantee must submit a typewritten report of his or her research progress 60 
days prior to the grant anniversary date of each year while the grant is in effect. 
The report shall be accompanied by an evaluation report from the Sponsor directly re- 
sponsible for the Grantee's work. Also, submitted with this report should be documen- 
tation of research results keyed to the field of leukemia and allied diseases together 
with any and all publications concerning said research. These reports shall be reviewed 
by the Society's Medical and Scientific Advisory Committee in order to evaluate the 
research progress of each of its Grantees. Although Scholarships are awarded for 
five-year period and Fellowships for a two-year period, the Society's Medical and 
Scientific Advisory Committee reserves the right to terminate any grant at its descretion. 
At the expiration of the grant period the Grantee shall submit a final report of the 
research conducted which shall include a recapitulation and summation of the research 
activities together with copies of all publications concerning said research written 
by the Grantee. 
6. The financial officer of the sponsoring institution must submit annual reports 
detailing how the grant funds were expended during the year. These reports shall be 
submitted within 60 days after each grant anniversary date. The sponsoring institution 
also agrees to submit a cumulative final accounting immediately upon completion or 
prior termination of the grant. Any unexpended funds must be returned to the Society. 
7. The Grantee and Sponsor will obtain approval from the sponsoring institution's 
Council on Human Investigation, if the application pertains to human research or the 
use of human materials. Those research projects which do not deal with the aforesaid 
regulation will furnish a letter signed by the Grantee and the Sponsor stating that: 
"The development of the research project at the present time does not involve the use 
of human subjects or human materials. Approval of the institution's Council on Human 
Investigation will be requested should such use occur and the Leukemia Society of 
America, Inc. will be so informed." 
8. The Grantee must include in the application a statement about any potential bio- 
hazards and a description of the safeguards planned where such hazards to the invest- 
igator, other personnel, or any other individuals may be encountered. 
The foregoing remarks express the major policies and procedures adopted by the Medical 
and Scientific Advisory Committee of the National Board of Trustees of the Leukemia 
Society of America 3 Inc. The policies as currently stated represent a revision of the 
announcement issued on March l 3 1963 and are subject to further revision at the dis- 
cretion of the Committee. Every effort will be made to cope with the special problems 
of investigators within the operational framework of this reseai'ch program. 
Revised April 3 1976 
[ 210 ] 
